arrow
X

Xavier Poiré

cliniques universitaires st luc
H指数:29
被引数:3,200

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS

在AML和MDS的RIC匹配供者PBSC移植中,使用PTCy、ATG、PTCy+ATG或无体内T细胞清除的GVHD预防

2026-09-120
PRE
ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC

ALLOPLUS:人类免疫缺陷病毒感染者儿童和成人的同种异基因造血干细胞移植,SFGM-TC的回顾性研究

2026-07-060
PRE
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC

HLA匹配造血干细胞移植中干细胞来源对首次完全缓解急性淋巴细胞白血病的影响:GRAALL和SFGM-TC的研究

2026-04-160
PRE
Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC

替代供者与匹配无关供者在首次完全缓解期接受移植的青少年和年轻急性髓系白血病患者中的比较:SFGM-TC 报告

2026-04-130
PRE
Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT

与ATG相比,在用无关供者进行异基因移植的骨髓纤维化患者中,移植后环磷酰胺可降低慢性移植物抗宿主病的发生率:EBMT慢性恶性疾病工作组的研究

2026-03-200
OAAI
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

DNMT3A基因突变对接受首次缓解期异基因移植的AML患者生存的影响,取决于核型及共现突变。

2025-12-230
PRE
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP

体细胞共发生突变在急性髓系白血病移植后结局中的频率和影响:一项代表EBMT ALWP的多中心登记研究

2025-12-050
PRE
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in amulti-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

TET2突变不影响接受造血干细胞移植且处于首次缓解期的成人急性髓系白血病患者的预后:欧洲血液与骨髓移植学会全球委员会和急性白血病工作组的多中心回顾性分析显示,配型相合的同胞或无关供者移植与单倍型相合供者移植后的结果相似。

2025-12-010
OAAI
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party

供者选择对不良风险AML接受造血细胞移植的影响:EBMT急性白血病工作组的研究

2025-11-290
PRE
Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class

微生态疗法与粪菌移植在血液肿瘤学中的应用:欧洲临床视角下,对演变中的监管框架和新兴治疗类别的导航

2025-11-290
PRE
Total-body irradiation-based versus chemotherapy alone as myeloablative conditioning regimen prior to hematopoietic allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia: a multi-institutional study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

全身照射为基础与单纯化疗作为成人急性淋巴细胞白血病患者造血同种异基因干细胞移植前骨髓清除性预处理方案:一项来自法语区骨髓移植与细胞治疗学会(SFGM-TC)的多中心研究

2025-10-220
PRE
Impact of Wilms’ tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry

WT1基因突变对急性髓系白血病异基因造血细胞移植结局的影响:一项来自ALWP/EBMT注册中心的回顾性多中心队列研究

2025-10-160
OA
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia

老年匹配同胞供者与年轻半相合供者用于老年急性髓系白血病患者

2025-07-180
OAAI
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT

异基因造血细胞移植治疗费城染色体阳性急性淋巴细胞白血病的老年患者。EBMT急性白血病工作组的研究。

2025-07-160
PRE
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)

异基因造血干细胞移植治疗老年急性淋巴细胞白血病患者:一项来自Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)的登记研究

2025-05-060
PRE
Allogeneic Stem-Cell Transplantation for Relapsed/Refractory ALK-Positive Anaplastic Large-Cell Lymphoma: A Study from the Societe Francophone De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)

异基因干细胞移植治疗复发/难治性ALK阳性间变性大细胞淋巴瘤:一项来自Societe Francophone De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)的研究

BLOOD
IF23.1
2024-11-050
PRE
In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

在首次缓解期接受异基因移植的AML患者中,DNMT3A突变根据核型、NPM1和FLT3-ITD突变状态对移植后结局产生差异性影响——来自EBMT-ALWP

BLOOD
IF23.1
2024-11-050
PRE